Ivacaftor restores G551D-cystic fibrosis transmembrane conductance regulator (CFTR) function in human bronchial epithelial (HBE) primary cell cultures.

Slides:

Advertisements

Similar presentations

Cystic Fibrosis: A Rheological Catastrophe CISMM: Center for Computer Integrated Systems for Microscopy and Manipulation Collaborators: Bill Davis 2, Ric.

Advertisements

Co-Transporters Na + /Glucose Symport Vibrio cholerae Prokaryote Water-bourne pathogen Produces Cholera Toxin.

METHODS Introduction Conclusions  The novel potentiator GP-2 is highly efficacious towards enhancing CFTR function following translational RT of PTCs,

Using additivity and bliss analysis to categorize corrector-corrector interactions Tim Vortherms*, Anne-Sophie Wesse, Arlene Manelli*, Andrew Swensen*,

Date of download: 6/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of Cystic Fibrosis Transmembrane Conductance.

Correcting Airway dehydration in Cystic Fibrosis BRETT ROLLINS

Bioelectric effects of quinine on polarized airway epithelial cells

Ivacaftor potentiation of multiple CFTR channels with gating mutations

Volume 2, Issue 3, Pages (September 1998)

Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair Claudia Bilodeau, Olivier Bardou, Émilie Maillé, Yves.

Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel Emanuela Pesce, Giulia Gorrieri,

Creation and characterization of an airway epithelial cell line for stable expression of CFTR variants Laura B. Gottschalk, Briana Vecchio-Pagan, Neeraj.

Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function Fredrick Van Goor, Haihui Yu, Bill.

Bioelectric effects of quinine on polarized airway epithelial cells

Effect of VX-770 (Ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells Laura Vachel, Caroline Norez, Frédéric.

Measurements of airway surface liquid height and mucus transport by fluorescence microscopy, and of ion composition by X-ray microanalysis Godfried M.

Rescue of misfolded recoded cystic fibrosis transmembrane conductance regulator (CFTR) channels. a) Representative Western blot obtained from HEK293 cells.

Readthrough levels measured for the indicated cystic fibrosis transmembrane conductance regulator (CFTR) premature termination codon mutations, at basal.

Ambra Gianotti, Valeria Capurro, Paolo Scudieri, Luis J. V

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone

Journal of Cystic Fibrosis

On the measurement of the functional properties of the CFTR

Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation Venkateshwar Mutyam,

Frank J. Accurso, Fredrick Van Goor, Jiuhong Zha, Anne J

Curcumin and genistein additively potentiate G551D-CFTR

Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,

The CF Salt Controversy

Function of recoded cystic fibrosis transmembrane conductance regulator (CFTR) channels. a) Representative recordings obtained from HEK293 cells expressing.

Maturation of recoded cystic fibrosis transmembrane conductance regulator (CFTR) channels. a) Representative Western blot obtained from HEK293 cells expressing.

ANO1: an additional key player in cyst growth

Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation Shahid I. Sheikh, Frederick R. Long, Karen.

Johanna F. Dekkers, Peter Van Mourik, Annelotte M

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Poster available online at:

The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation Verena I. Seliger, David Rodman, Fredrick Van.

Pathological changes of the central airways in chronic obstructive pulmonary disease. a) A central bronchus from the lung of a cigarette smoker with normal.

Combination potentiator (‘co-potentiator’) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators

Representative photomicrograph of small airways abnormalities in a subject with chronic obstructive pulmonary disease. Representative photomicrograph of.

Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

The events that lead to airway narrowing and a reduction in forced expiratory volume in 1 s in response to different indirect challenge tests. The events.

Histological evidence of alveolar epithelial cells undergoing epithelial-mesenchymal transition in response to transforming growth factor-β1. a–c) α-smooth.

Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr−/− mice Sabrina Noël, Pierre-Olivier Strale, Luc Dannhoffer, Martina.

Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Prevalence of chronic bronchitis in relation to active smoking, stratified by age. □: nonsmokers; ▒: 1–10 cigarettes per day; ░: 11–20 cigarettes per day;

a) Accurate bronchial skeleton.

Volume 18, Issue 2, Pages (February 2011)

Pilot evaluation of ivacaftor for chronic bronchitis

CD11b+ alveolar macrophages in idiopathic pulmonary fibrosis (IPF) develop tube-like structures in vitro. CD11b+ alveolar macrophages in idiopathic pulmonary.

Design of adult and paediatric studies investigating the efficacy and tolerability of ivacaftor [16, 17]. Design of adult and paediatric studies investigating.

Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells by Sami Mamand, Matthew Carr,

Kaplan–Meier survival curves for outcomes among chronic obstructive pulmonary disease (COPD) patients without obstructive sleep apnoea (OSA) (COPD group),

a) The Spiration (Spiration, Inc. , Redmond, WA, USA) device

Histological evidence for endothelin (ET)-1 induction of epithelial-mesenchymal transition in rat primary distal epithelial cells. a–c) Control, d–f) ET-1.

Proteinase activated receptor-1 expression in a) weak immunostaining in normal lung tissue, b) intense immunostaining in idiopathic pulmonary fibrosis,

Kaplan–Meier curves for the probability of a first adjudicated primary end-point event in the AMBITION trial, suggesting that the primary outcome events.

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Comparison between prediction equations from Wang et al

Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic.

Significance of the principal genetic variants associated with familial pulmonary fibrosis by their strength and frequency. Significance of the principal.

Fluorescence confocal micrograph images of human ciliated nasal epithelial cells showing presence (normal) or absence (examples here from different primary.

Bacterial sputum microbiomes of a, c) an exocrine pancreas insufficient (PI) cystic fibrosis (CF) patient who is homozygous for the most common cystic.

Apart from their well-established presence in the conducting airways, mast cells in the human respiratory system are also abundant in other key compartments.

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations are categorised into six classes. Cystic fibrosis transmembrane conductance regulator.

Hyperplastic alveolar epithelial type II cells show severe endoplasmic reticulum stress and consecutive apoptosis. Hyperplastic alveolar epithelial type.

Correlation of sweat chloride levels with cystic fibrosis transmembrane conductance regulator (CFTR) protein expression and function. Correlation of sweat.

Pdcd4 expression inhibits AP-1 transactivation.

24-h blood pressure profile after a, d) one night of intermittent hypoxia (IH) exposure, b, e) 13 nights IH exposure and c, f) 5 days after cessation of.

High-resolution computed tomography images of smoking-related interstitial lung diseases (ILDs). a) Pulmonary Langerhans cell histiocytosis, b) respiratory.

Presentation transcript:

Ivacaftor restores G551D-cystic fibrosis transmembrane conductance regulator (CFTR) function in human bronchial epithelial (HBE) primary cell cultures. a) CFTR activity was evaluated by measuring CFTR-dependent chloride transport (short-circuit current in v... Ivacaftor restores G551D-cystic fibrosis transmembrane conductance regulator (CFTR) function in human bronchial epithelial (HBE) primary cell cultures. a) CFTR activity was evaluated by measuring CFTR-dependent chloride transport (short-circuit current in voltage-clamp mode) relative to wild-type (n=16). Ivacaftor increased the activity of G551D/F508del-CFTR to ∼50% of wild-type (personal communication; F. van Goor, Vertex Pharmaceuticals Inc., Cambridge, MA, USA). Modified from [54]. b) Mean ciliary beat frequency (CBF) after 5 days of treatment with dimethyl sulfoxide (DMSO), 30 nM vasoactive intestinal peptide (VIP) (a naturally occuring CFTR activator), 10 μM ivacaftor (IVA), or 30 nM VIP+10 μM IVA (±sem; n=6). Taken together, the results show that IVA (either alone or in combination with VIP) caused a significant increase in CBF with respect to vehicle control (DMSO). Modified from [52]. *: p<0.05, significant difference between DMSO and G551D/F508del-HBE; #: p<0.05, significant difference between DMSO and IVA alone. c) Representative confocal microscopy image of G551D/F508del-HBE cultures treated with vehicle control or ivacaftor. The results show a clear ivacaftor-dependent increase in the depth of airway surface liquid (ASL) relative to control (personal communication; F. van Goor, Vertex Pharmaceuticals Inc., Cambridge, MA, USA). Modified from [52]. d) Dose–response curve of the change in ASL volume in G551D/F508del-HBE after application of ivacaftor at the indicated concentrations (n=3–9). Reproduced from [52]. Nico Derichs Eur Respir Rev 2013;22:58-65 ©2013 by European Respiratory Society